Efficacy of regimens combining direct acting antiviral agents for hepatitis C virus recombinant form RF1_2k/1b

被引：1
|
作者：
Matsuura, Kentaro [1 ]
Tanaka, Yasuhito [2 ]
机构：
[1] Nagoya City Univ, Dept Gastroenterol & Metab, Grad Sch Med Sci, Nagoya, Aichi, Japan
[2] Nagoya City Univ, Dept Virol & Liver Unit, Grad Sch Med Sci, Nagoya, Aichi, Japan
来源：
HEPATOLOGY RESEARCH | 2018年 / 48卷 / 01期
关键词：
INTERGENOTYPIC RECOMBINANT; MOLECULAR EPIDEMIOLOGY; 2K/1B; SOFOSBUVIR; RIBAVIRIN; GENOTYPES; STRAINS;
D O I：
10.1111/hepr.12903
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [31] Real World Hepatitis B Virus Screening Rates in Hepatitis C patients treated with Direct-Acting Antiviral Agents
    Shokoohi, Susanne
    Sebhatu, Phoebe
    Ansong, Joelitta
    Mitchell, Justin
    Janardhan, Sujit V.
    Aloman, Costica
    Shah, Nikunj N.
    Jensen, Donald M.
    Reau, Nancy
    Eswaran, Sheila
    HEPATOLOGY, 2017, 66 : 820A - 821A
  • [32] Emergence of NS5A Rass Among HCV RF1_2k/1b Patients Treated within Georgian Hepatitis C Elimination Program: A Case Report
    Tsertsvadze, Tengiz
    Karchava, Marine
    Svanidze, Mariam
    Sharvadze, Lali
    HEPATOLOGY, 2018, 68 : 599A - 599A
  • [33] Direct-Acting Antiviral Use for Genotype 1b Hepatitis C Patients with Associated Hematological Disorders from Romania
    Marincu, Iosif
    Bratosin, Felix
    Curescu, Manuela
    Suciu, Oana
    Turaiche, Mirela
    Cerbu, Bianca
    Vidican, Iulia
    MEDICINA-LITHUANIA, 2021, 57 (09):
  • [34] Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications
    Bednasz, Cindy J.
    Venuto, Charles S.
    Ma, Qing
    Morse, Gene D.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (02): : 135 - 139
  • [35] A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines
    Kageyama, Seiji
    Agdamag, Dorothy M.
    Alesna, Evelyn T.
    Leano, Prisca S.
    Heredia, Anna Marie L.
    Abellanosa-Tac-An, Ilya P.
    Jereza, Lourdes D.
    Tanimoto, Tomoaki
    Yamamura, Jun-ichi
    Ichimura, Hiroshi
    JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (11) : 1423 - 1428
  • [36] Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
    Kanda, Tatsuo
    Nirei, Kazushige
    Matsumoto, Naoki
    Higuchi, Teruhisa
    Nakamura, Hitomi
    Yamagami, Hiroaki
    Matsuoka, Shunichi
    Moriyama, Mitsuhiko
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (46) : 8120 - 8127
  • [37] Three Children Treated with Direct-acting Antivirals for Chronic Hepatitis C Virus Genotype 1b Infection
    Ohya, Kazuki
    Kawaoka, Tomokazu
    Imamura, Michio
    Morio, Kei
    Nakahara, Takashi
    Murakami, Eisuke
    Yamauchi, Masami
    Hiramatsu, Akira
    Tsuge, Masataka
    Aikata, Hiroshi
    Chayama, Kazuaki
    INTERNAL MEDICINE, 2020, 59 (07) : 941 - 944
  • [38] Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b
    Ogasawara, Nobuhiko
    Kobayashi, Masahiro
    Akuta, Norio
    Kominami, Yoko
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Sezaki, Hitomi
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Saitoh, Satoshi
    Suzuki, Yoshiyuki
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (02) : 313 - 319
  • [39] Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia
    Zakalashvili, Mamuka
    Zarkua, Jaba
    Weizenegger, Michael
    Bartel, Jan
    Raabe, Monika
    Zangurashvili, Lela
    Kankia, Nino
    Jashiashvili, Nino
    Lomidze, Maka
    Telia, Tengiz
    Kerashvili, Vakhtang
    Zhamutashvili, Maia
    Abramishvili, Nikoloz
    Hedskog, Charlotte
    Chodavarapu, Krishna
    Brainard, Diana M.
    McHutchison, John G.
    Mo, Hongmei
    Svarovskaia, Evguenia
    Gish, Robert G.
    Rtskhiladze, Irakli
    Metreveli, David
    LIVER INTERNATIONAL, 2018, 38 (03) : 451 - 457
  • [40] PREVALENCE AND CLINICAL IMPORTANCE OF HEPATITIS C VIRUS GENOTYPE 2 K/1B CHIMERAS
    Susser, S.
    Dietz, J.
    Barak, M.
    Schlevogt, B.
    Daniel, R.
    Piazzolla, V.
    Passmann, S.
    Cornberg, M.
    Zuckerman, E.
    Mangia, A.
    Zeuzem, S.
    Sarrazin, C.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S136 - S136
12345